U.S., Feb. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07381322) titled 'A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI' on Jan. 25.

Brief Summary: This project aims to use multi-temporal, multi-parameter MRI features, blood biomarkers, and clinical indicators to accurately assess pseudoprogression following immunotherapy in rectal cancer.

Study Start Date: Jan. 30

Study Type: OBSERVATIONAL

Condition: Rectal

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Peiyi Xie

Information provided by (Responsible Party): Peiyi Xie, Sixth Affiliated Hospital, Sun Yat-sen University

Disclaimer: Curated by HT Syndication....